All Testosterone Therapy Drugs Need To Warn About Blood Clots Side Effects Like DVT And PE; Older Depo-Testosterone Product May Be Safer Than New Gels Such As AndroGel And Testim
SUMMARY: We will start with two recent FDA developments:
1. Testosterone: Drug Information Update- FDA adding general warning to testosterone products about potential for venous blood clots [Issued 6/19/14]
2. Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS) between January – March 2014 [Page / List Updated 6/16/14]
Now we shift to the medical journals and, in particular, an article published online July 2, 2014 by the Annals of Pharmacotherapy, “Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy”.
We will continue to monitor this still emerging drug safety issue concerning Depo-Testosterone, Testim, AndroGel, Axiron, and other testosterone products — also called TRT and/or “Low-T” drugs.[Read this article in full at original source]